unknown by Pinder, Roger M
Neuropsychiatric Disease and Treatment 2005:1(1) 1–1
© 2005 Dove Medical Press Limited. All rights reserved
1
EDITORIAL FOREWORD
Volume 1 – Number 1 – 2005
New journals generally face a difficult gestation. Finding publishers, appointing
editors, recruiting Editorial Board members, calling for manuscripts, selecting peer-
reviewers who will deliver on time and finding substitutes when they do not; and all
of this without accreditation at the major medical indexes, making authors
understandably reluctant to commit their best work when it cannot yet be cited.1
Neuropsychiatric Disease and Treatment (NDT) is no exception, but did have the
good fortune that publisher Dove Medical Press was available and fully supportive.
Why a new journal in the crowded area of neuroscience? The idea for NDT began
in Dove Medical Press when we felt a real place where neurology could meet
psychiatry and where patient and caregiver needs and concerns could be addressed
in the public scientific domain was needed. The emergence of imaging as an everyday
tool, coupled with our growing ability to identify discrete areas of the brain that are
involved in disease and the corresponding neurochemical and neuropathological
processes, has served to blur the divide between the two specialties. Many neurological
conditions present with psychiatric symptoms, and vice-versa; drugs useful in one
specialty are often applied in the other; while the side effects of many of the treatments
that we use for the two types of illness are not necessarily confined to the psychiatric
or neurological domains. The importance of this crossover area of research was
affirmed by the interest of the International Neuropsychiatric Association (INA) in
having NDT as its house journal.
In the first issue we have tried to encourage this vision with articles on the
regulation of affect and on the most prevalent affective disorder, depression, including
the way in which patient characteristics can determine response to antidepressant
treatment, together with others on cognition in Parkinson’s disease and the genetics
and brain morphology of patients with Alzheimer’s disease. We also encourage the
submission of experimental animal studies that illustrate and inform on aspects of
human conditions, hence a paper on an experimental model of post-traumatic stress
disorder. In addition to the Commentary, Reviews, Original Research, and Letters
appearing in this issue, we do plan to publish Case Reports and Expert Opinion. I
wish to thank the members of our editorial board, reviewers, authors, and Dove
Medical Press for their tremendous help in preparing this inaugural issue.
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1 Neuropsychiatric Disease and Treatment will be eligible to be considered for online indexing later
in 2005.
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